Cargando…
Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation
Ovarian cancer is one of the most common cancer among women in the world, and chemotherapy remains the principal treatment for patients. However, drug resistance is a major obstacle to the effective treatment of ovarian cancers and the underlying mechanism is not clear. An increased understanding of...
Autores principales: | Ji, Yanlong, Wei, Shasha, Hou, Junjie, Zhang, Chengqian, Xue, Peng, Wang, Jifeng, Chen, Xiulan, Guo, Xiaojing, Yang, Fuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355108/ https://www.ncbi.nlm.nih.gov/pubmed/28077793 http://dx.doi.org/10.18632/oncotarget.14542 |
Ejemplares similares
-
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors
por: Li, Qing Kay, et al.
Publicado: (2017) -
Glycoproteins and glycoproteomics in pancreatic cancer
por: Pan, Sheng, et al.
Publicado: (2016) -
Proteome and Glycoproteome Analyses Reveal the Protein N-Linked Glycosylation Specificity of STT3A and STT3B
por: Wen, Piaopiao, et al.
Publicado: (2022) -
Targeted glycoproteomic identification of cancer cell glycosylation
por: Powlesland, Alex S, et al.
Publicado: (2009) -
Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020)